Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of RM-003 in homocystinuria
jRCT2080221773Phase 3
- Sponsor
- ReqMed Company, Ltd.
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of betaine anhydrous in homocystinuria (HCU), Cystathionine beta-synthase deficiency (CBS), methylenetetrahydrofolate reductase deficiency and 1 more, sponsored by ReqMed Company, Ltd.
02
Drugs
betaine anhydrous
03
Conditions
homocystinuria (HCU)Cystathionine beta-synthase deficiency (CBS)methylenetetrahydrofolate reductase deficiencydisorder of cobalamin cofactor metabolism
Beyond the preview
Go deeper on jRCT2080221773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221773.